Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• New data, updated guidance ‘dramatically’ changing HF treatment landscape Regina Schaffer; Erik Swain
• Acetazolamide improves congestion at 3 days in acute decompensated HF Scott Buzby
• Addition of sleep metric in updated Life’s Essential 8 predicts CVD incidence Regina Schaffer
• AF screening may lower cost, increase QALYs in older adults Scott Buzby
• Black patients less likely to receive VADs, heart transplants than white patients Erik Swain
• Chinese herbal medicine may improve outcomes after STEMI Scott Buzby
• DCBs may be superior to bare-metal stents in patients with femoropopliteal artery disease Erik Swain
• Eating refined grains may raise premature CAD risk Regina Schaffer
• Esports may raise risk for cardiac arrythmias, sudden death in susceptible children Regina Schaffer
• In obesity, treat excess weight first to address underlying cardiometabolic disease Regina Schaffer
• Initial cryoballoon ablation strategy bests drug therapy for long-term AF progression Regina Schaffer
• LAAO device usage up, major adverse events down over time Erik Swain
• Lost opportunities for prevention if clinicians adopt USPSTF statin recommendations Aardra Rajendran, MD; Matthew Belanger, MD; Neil Stone, MD; Roger S. Blumenthal, MD
• Masked hypertension ‘real phenomenon’ driving cardiometabolic risk Regina Schaffer
• Mindfulness may offer an ‘appealing approach’ to lower blood pressure Katie Kalvaitis
• No difference in CV outcomes with two common diuretics among veterans with hypertension Scott Buzby
• Olpasiran cut Lp(a) levels by more than 95% in patients with atherosclerotic CVD Katie Kalvaitis
• Particle radioactivity exposure from radon gas linked to CVD mortality Regina Schaffer
• PE-related deaths increased through 2020, regardless of COVID-19 status Scott Buzby
• PROMISE II: Deep venous arterialization boosts amputation-free survival in severe CLI Erik Swain
• ‘Quad therapy’ strategy may improve BP control vs. angiotensin receptor blocker monotherapy Scott Buzby
• Remote BP, cholesterol management program may optimize guideline-directed therapy Regina Schaffer
• ‘Take the extra time’: Assess mental health at every cardiology visit Regina Schaffer; Fidelis Mkparu, MD, FACC
• BEST-CLI
• EMPA-KIDNEY
• PROGRESSIVE-AF
• SPORT